8-K

Company

Viking Therapeutics, Inc.

Filed

November 5, 2019

Period of Report

November 5, 2019

Accession Number

0001564590-19-040059

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →